drugset / Trial / NCT02836470
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to establish preliminary evidence of the efficacy, safety, and tolerability of LB1148 for the treatment of post-operative ileus and intra-abdominal adhesions in subjects undergoing elective bowel resection.
Timeline
- Start
- 2019-10-01
- Primary completion
- 2023-09-06
- Completion
- 2023-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 700 ml | Oral |